The invention relates to the field of medicines relevant to
diabetes mellitus, in particular to a type 2
sodium galactose transporter [SGLT2 (
sodium-dependent
glucose transporter)] inhibitor of a C-
glucoside type containing a
cyclopropane structure, a preparation method of the type 2
sodium galactose transporter inhibitor, a medicinal composition containing the type 2 sodium
galactose transporter inhibitor and application of the type 2 sodium galactose transporter inhibitor in terms of preparation of
medicine for the
diabetes mellitus. An R1 is one of H, F, Cl, Br, I, OR3, SR4, OCF3, CF3, CHF2, CH2F,
alkyl of C1-C3 and a naphthenic base containing 3-5 carbon atoms, an R3 and an R4 are independently selected from
alkyl of C1-C3, an R2 is selected from
alkyl of C1-C3, cyclopropyl and OR5, and an R5 is one of alkyl of C1-C3 and cyclopropyl.